Published in Gene Ther on February 26, 2009
Viral and nonviral delivery systems for gene delivery. Adv Biomed Res (2012) 1.42
HSV Recombinant Vectors for Gene Therapy. Open Virol J (2010) 0.99
Gene therapy as future treatment of erectile dysfunction. Expert Opin Biol Ther (2010) 0.81
Development of viral vectors for gene therapy for chronic pain. Pain Res Treat (2011) 0.81
Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception. Hum Gene Ther (2013) 0.81
Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine. Genes Dis (2017) 0.75
Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor. Nature (1979) 6.56
Neurotransmitters decrease the calcium conductance activated by depolarization of embryonic chick sensory neurones. J Physiol (1981) 3.61
Cloning of a delta opioid receptor by functional expression. Science (1992) 3.49
Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin/dynorphin precursor. Nature (1982) 3.09
Epidemiology of interstitial cystitis: a population based study. J Urol (1999) 2.85
Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Natl Acad Sci U S A (1996) 2.84
The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci U S A (1992) 2.84
Cloning and sequence analysis of cDNA for bovine adrenal preproenkephalin. Nature (1982) 2.79
Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol (1993) 2.54
Activation of unmyelinated afferent fibres by mechanical stimuli and inflammation of the urinary bladder in the cat. J Physiol (1990) 2.53
The control of pain in peripheral tissue by opioids. N Engl J Med (1995) 2.48
PGE2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. J Physiol (1996) 2.46
Multiple opiate receptor sites on primary afferent fibres. Nature (1980) 2.34
Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J Neurosci (1999) 2.25
Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol (2007) 2.24
Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature (1980) 2.08
Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology (1997) 1.98
A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol (2003) 1.93
Organization of the sacral parasympathetic reflex pathways to the urinary bladder and large intestine. J Auton Nerv Syst (1981) 1.88
Peripheral mechanisms of opioid analgesia. Anesth Analg (1993) 1.81
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc Natl Acad Sci U S A (1993) 1.77
Functional properties of spinal visceral afferents supplying abdominal and pelvic organs, with special emphasis on visceral nociception. Prog Brain Res (1986) 1.75
Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev (1996) 1.74
Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol (2005) 1.69
Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron (1993) 1.68
Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology (2001) 1.59
Effect of pentosan polysulfate therapy on intravesical potassium sensitivity. Urology (2002) 1.57
Peripheral morphine analgesia. Pain (1997) 1.49
Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats. J Neurosci (2006) 1.48
Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci U S A (1993) 1.47
Segmental distribution and peptide content of primary afferent neurons innervating the urogenital organs and colon of male rats. J Comp Neurol (1992) 1.47
Neural control of the lower urinary tract. Int J Urol (1997) 1.46
Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol (1999) 1.45
Organization of afferent and efferent pathways in the pudendal nerve of the female cat. J Comp Neurol (1989) 1.41
Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther (2001) 1.41
Pharmacology of the lower urinary tract. Annu Rev Pharmacol Toxicol (2001) 1.41
Herpes vector-mediated expression of proenkephalin reduces bone cancer pain. Ann Neurol (2002) 1.40
mu opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci U S A (1993) 1.39
Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review. Arch Intern Med (2007) 1.38
The distribution of visceral primary afferents from the pelvic nerve to Lissauer's tract and the spinal gray matter and its relationship to the sacral parasympathetic nucleus. J Comp Neurol (1981) 1.38
Interstitial cystitis and painful bladder syndrome. J Urol (2007) 1.37
Myelinated primary afferents of the sacral spinal cord responding to slow filling and distension of the cat urinary bladder. J Physiol (1993) 1.36
Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol (2005) 1.35
Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. Biochem J (1993) 1.34
Mechanosensitive properties of pelvic nerve afferent fibers innervating the urinary bladder of the rat. J Neurophysiol (1994) 1.33
A model for the study of visceral pain states: chronic inflammation of the chronic decerebrate rat urinary bladder by irritant chemicals. Pain (1987) 1.32
The inhibitory effect of opioid peptides and morphine applied intrathecally and intracerebroventricularly on the micturition reflex in the cat. Brain Res (1984) 1.31
Long-term results of amitriptyline treatment for interstitial cystitis. J Urol (2005) 1.31
Prostaglandins suppress an outward potassium current in embryonic rat sensory neurons. J Neurophysiol (1997) 1.28
Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology (2005) 1.27
Electrophysiological study of micturition reflexes in rats. Am J Physiol (1989) 1.25
Sensitisation of visceral afferents by nerve growth factor in the adult rat. Pain (1996) 1.24
Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer. J Clin Invest (2005) 1.23
A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol (2004) 1.22
Evaluation of intra-operative tramadol for prevention of catheter-related bladder discomfort: a prospective, randomized, double-blind study. Br J Anaesth (2008) 1.20
Interstitial cystitis: current issues and controversies in diagnosis. Urology (2001) 1.18
Molecular cloning and expression of a rat kappa opioid receptor. Biochem J (1993) 1.16
Inhibition of urinary bladder contractions by a spinal action of morphine and other opioids. J Pharmacol Exp Ther (1984) 1.15
Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes. FEBS Lett (1993) 1.13
Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins. Exp Brain Res (1995) 1.12
A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis. BJU Int (2008) 1.10
Abnormal excitability in capsaicin-responsive DRG neurons from cats with feline interstitial cystitis. Exp Neurol (2005) 1.10
Pharmacological modulation of the pontine micturition center. Brain Res (1991) 1.07
Opioid agonists and antagonists: an evaluation of their peripheral actions in inflammation. Med Res Rev (1992) 1.06
Effects of opioids on mechanosensitive pelvic nerve afferent fibers innervating the urinary bladder of the rat. J Neurophysiol (1997) 1.04
Cloning and expression of a cDNA for the rat kappa-opioid receptor. FEBS Lett (1993) 1.04
Epidemiology of interstitial cystitis. Ann Chir Gynaecol Fenn (1975) 1.03
Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study. J Urol (2000) 1.03
Analysis of the afferent limb of the vesicovascular reflex using neurotoxins, resiniferatoxin and capsaicin. Am J Physiol Regul Integr Comp Physiol (2001) 1.02
Intravesical gene therapy: in vivo gene transfer using recombinant vaccinia virus vectors. Cancer Res (1994) 1.01
Heterogeneous sensitivity of cultured dorsal root ganglion neurones to opioid peptides selective for mu- and delta-opiate receptors. Nature (1982) 1.01
Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Hum Gene Ther (2009) 1.01
Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction. J Urol (2001) 1.01
Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol (1996) 1.01
Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. J Pharmacol Exp Ther (1995) 1.00
Regulation of urinary bladder capacity by endogenous opioid peptides. J Urol (1985) 0.99
The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy. Rev Urol (2002) 0.98
Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes (2004) 0.97
Recent advances in intravesical drug/gene delivery. Mol Pharm (2006) 0.97
Urine markers of interstitial cystitis. Urology (2001) 0.95
Effects of intravesical instillation of resiniferatoxin on bladder function and nociceptive behavior in freely moving, conscious rats. J Urol (2007) 0.95
Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome. Scand J Urol Nephrol (2005) 0.93
Molecular cloning and in situ hybridization histochemistry for rat mu-opioid receptor. Neurosci Res (1994) 0.93
Kappa opiate agonists inhibit Ca2+ influx in rat spinal cord-dorsal root ganglion cocultures. Involvement of a GTP-binding protein. J Biol Chem (1989) 0.91
Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain. Tech Urol (2001) 0.91
Delta opioid receptor mRNA distribution in the brain: comparison to delta receptor binding and proenkephalin mRNA. J Chem Neuroanat (1994) 0.91
Effect of lumbar-epidural administration of tramadol on lower urinary tract function. Neurourol Urodyn (2008) 0.91
Selective inhibitory effects of ethylketocyclazocine on reflex pathways to the external urethral sphincter of the cat. J Pharmacol Exp Ther (1989) 0.89
Spinal cord projections and neuropeptides in visceral afferent neurons. Prog Brain Res (1986) 0.89
cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for kappa-subtype-selective ligands. FEBS Lett (1993) 0.89
Identification of pretreatment agents to enhance adenovirus infection of bladder epithelium. Mol Ther (2004) 0.89
Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology (2005) 0.88
Interstitial cystitis: update on etiologies and therapeutic options. J Womens Health Gend Based Med (1999) 0.88
Gene therapy strategies for urological dysfunction. Trends Mol Med (2001) 0.88
Toxic factors in human urine that injure urothelium. Int J Urol (2006) 0.87
Gene therapy applications for the treatment of neuropathic pain. Expert Rev Neurother (2007) 0.86
Opiate receptors in cultures of fetal mouse dorsal root ganglia (DRG) and spinal cord: predominance in DRG neurites. Brain Res (1978) 0.85
Alterations in neural pathways to the urinary bladder of the rat in response to streptozotocin-induced diabetes. J Auton Nerv Syst (1994) 0.85
Interstitial cystitis. Curr Opin Urol (1999) 0.84
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Cloning of herpes simplex virus type 1 sequences representing the whole genome. J Virol (1981) 5.66
Transcriptional and genetic analyses of the herpes simplex virus type 1 genome: coordinates 0.29 to 0.45. J Virol (1984) 4.09
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med (2001) 4.02
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J Virol (1987) 3.74
The actions of gamma-aminobutyric acid and related amino acids on mammalian autonomic ganglia. J Pharmacol Exp Ther (1970) 2.97
High-frequency transfer of cloned herpes simplex virus type 1 sequences to mammalian cells by protoplast fusion. Mol Cell Biol (1981) 2.97
Physical mapping of the mutation in an antigenic variant of herpes simplex virus type 1 by use of an immunoreactive plaque assay. J Virol (1983) 2.96
IOF position statement: vitamin D recommendations for older adults. Osteoporos Int (2010) 2.79
Mutations in herpes simplex virus type 1 genes encoding VP5 and VP23 abrogate capsid formation and cleavage of replicated DNA. J Virol (1993) 2.79
Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA. Mol Cell Biol (1986) 2.65
The pseudorabies virus gII gene is closely related to the gB glycoprotein gene of herpes simplex virus. J Virol (1987) 2.58
Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis. Science (1987) 2.57
Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int (2012) 2.48
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J Neurosci (1999) 2.25
Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci U S A (2001) 2.17
Expression of herpes simplex virus beta and gamma genes integrated in mammalian cells and their induction by an alpha gene product. Mol Cell Biol (1983) 2.15
Reflexes to sacral parasympathetic neurones concerned with micturition in the cat. J Physiol (1969) 2.12
A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene. Genes Dev (1988) 2.11
Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration. J Virol (1988) 1.94
Immune interactions with cells infected with herpes simplex virus: antibodies to radioiodinated surface antigens. J Immunol (1977) 1.94
Possible role of Fc receptors on cells infected and transformed by herpesvirus: escape from immune cytolysis. Infect Immun (1978) 1.93
Prevalence of radiographic knee osteoarthritis and its association with knee pain in the elderly of Japanese population-based cohorts: the ROAD study. Osteoarthritis Cartilage (2009) 1.90
Method for induction of mutations in physically defined regions of the herpes simplex virus genome. J Virol (1981) 1.89
Organization of the sacral parasympathetic reflex pathways to the urinary bladder and large intestine. J Auton Nerv Syst (1981) 1.88
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol (1994) 1.86
Inversion events in the HSV-1 genome are directly mediated by the viral DNA replication machinery and lack sequence specificity. Cell (1988) 1.84
Antigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D, using deletion mutants and monoclonal antibody-resistant mutants. J Virol (1988) 1.74
Control of rabbit liver fructose-1, 6-diphosphatase activity by magnesium ions. J Biochem (1975) 1.74
B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation. J Exp Med (1983) 1.73
Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium. Am J Physiol Renal Physiol (2003) 1.73
Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates. J Biol Chem (1984) 1.70
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci U S A (1999) 1.68
Regulation of the herpes simplex virus type 1 late (gamma 2) glycoprotein C gene: sequences between base pairs -34 to +29 control transient expression and responsiveness to transactivation by the products of the immediate early (alpha) 4 and 0 genes. Nucleic Acids Res (1987) 1.68
Fully automatic quantification of knee osteoarthritis severity on plain radiographs. Osteoarthritis Cartilage (2008) 1.67
Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci U S A (1993) 1.65
Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc Natl Acad Sci U S A (2001) 1.65
HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther (2005) 1.63
Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B. J Virol (1993) 1.63
Optical coherence tomographic pattern and focal electroretinogram in patients with retinitis pigmentosa. Eye (Lond) (2008) 1.62
Recurrent histiocytic necrotizing lymphadenitis (Kikuchi's disease) in an human T lymphotropic virus type I carrier. Intern Med (1996) 1.60
Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites. J Virol (1985) 1.60
Noninvasive urodynamic evaluation of bladder outlet obstruction using Doppler ultrasonography. Urology (2000) 1.54
Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol (2001) 1.54
Identification of mar mutations in herpes simplex virus type 1 glycoprotein B which alter antigenic structure and function in virus penetration. J Virol (1989) 1.52
Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain. J Virol (1994) 1.51
Developmental and injury induced plasticity in the micturition reflex pathway. Behav Brain Res (1998) 1.51
Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol Renal Physiol (2004) 1.50
Expression of cyclooxygenase-2 in prostate carcinoma. Cancer (2000) 1.49
The role of plasma amino acids in hepatic encephalopathy. Surgery (1975) 1.49
Antigenic and functional analysis of a neutralization site of HSV-1 glycoprotein D. Virology (1990) 1.49
Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules. Proc Natl Acad Sci U S A (1981) 1.48
Mutant analysis of herpes simplex virus-induced cell surface antigens: resistance to complement-mediated immune cytolysis. J Virol (1980) 1.48
Magnifying endoscopy combined with narrow-band imaging for differential diagnosis of superficial depressed gastric lesions. Endoscopy (2009) 1.47
Neural control of the lower urinary tract. Int J Urol (1997) 1.46
Changes in bladder and external urethral sphincter function after spinal cord injury in the rat. Am J Physiol (1993) 1.45
Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity. J Virol (1985) 1.45
1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.45
Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol (1999) 1.45
Cardiac metastasis of lung cancer. A study of metastatic pathways and clinical manifestations. Cancer (1992) 1.44
Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol (1997) 1.43
HSV trafficking and development of gene therapy vectors with applications in the nervous system. Gene Ther (2005) 1.42
Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. J Urol (1999) 1.41
Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther (2001) 1.41
Pharmacology of the lower urinary tract. Annu Rev Pharmacol Toxicol (2001) 1.41
Methylprednisolone inhibits endotoxin-induced depression of contractile function in human arteries in vitro. Br J Anaesth (1996) 1.40
Utility of duplex Doppler ultrasound in evaluating portal hypertension in children. J Pediatr Gastroenterol Nutr (1995) 1.40
Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production. J Virol (1986) 1.39
Vitreous surgery for traumatic macular holes. Retina (1999) 1.39
Urinary incontinence among community-dwelling people aged 40 years or older in Japan: prevalence, risk factors, knowledge and self-perception. Int J Urol (2000) 1.38
Genetic variants of CYP19 (aromatase) and breast cancer risk. Oncogene (2000) 1.38
The distribution of visceral primary afferents from the pelvic nerve to Lissauer's tract and the spinal gray matter and its relationship to the sacral parasympathetic nucleus. J Comp Neurol (1981) 1.38
Identifying pathogenic genetic background of simplex or multiplex retinitis pigmentosa patients: a large scale mutation screening study. J Med Genet (2008) 1.38
Neurogenic bladder induced by brain abscess. Br J Urol (1995) 1.38
Gene transfer to synoviocytes: prospects for gene treatment of arthritis. DNA Cell Biol (1992) 1.37
Effect of cross-immunization on monotypic antibody responses to herpes simplex virus types 1 and 2. J Immunol (1976) 1.37
Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections. J Virol (1995) 1.37
Gene transfer to interfere with TNFalpha signaling in neuropathic pain. Gene Ther (2007) 1.37
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther (1998) 1.36
Gene transfer to neurons using herpes simplex virus-based vectors. Annu Rev Neurosci (1996) 1.35
Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate. J Gen Virol (1994) 1.35
Molecular basis of the glycoprotein C-negative phenotypes of herpes simplex virus type 1 mutants selected with a virus-neutralizing monoclonal antibody. J Virol (1986) 1.33
Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology (1977) 1.33
Prevalence of radiographic lumbar spondylosis and its association with low back pain in elderly subjects of population-based cohorts: the ROAD study. Ann Rheum Dis (2008) 1.33
Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab (1997) 1.33
The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2003) 1.32
Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg (1974) 1.32
Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis. J Urol (1999) 1.32
Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther (1996) 1.31
The inhibitory effect of opioid peptides and morphine applied intrathecally and intracerebroventricularly on the micturition reflex in the cat. Brain Res (1984) 1.31
Heterogeneity of muscarinic receptor-mediated Ca2+ responses in cultured urothelial cells from rat. Am J Physiol Renal Physiol (2008) 1.30
Influence of spinal cord injury on the morphology of bladder afferent and efferent neurons. J Auton Nerv Syst (1995) 1.30
A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome. J Virol (1992) 1.29
Effect of capsaicin on micturition and associated reflexes in chronic spinal rats. Brain Res (1995) 1.29
Bladder and sphincter behavior in patients with spinal cord lesions. J Urol (1991) 1.28
Pontine control of the urinary bladder and external urethral sphincter in the rat. Brain Res (1990) 1.28